{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:44:59Z","timestamp":1774568699402,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.1038\/5082","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:50:09Z","timestamp":1027673409000},"page":"128-132","source":"Crossref","is-referenced-by-count":220,"title":["Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma"],"prefix":"10.1038","volume":"21","author":[{"given":"Ling","family":"Liu","sequence":"first","affiliation":[]},{"given":"David","family":"Dilworth","sequence":"additional","affiliation":[]},{"given":"Luzhang","family":"Gao","sequence":"additional","affiliation":[]},{"given":"Jose","family":"Monzon","sequence":"additional","affiliation":[]},{"given":"Ann","family":"Summers","sequence":"additional","affiliation":[]},{"given":"Norman","family":"Lassam","sequence":"additional","affiliation":[]},{"given":"David","family":"Hogg","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFng0199_128_CR1","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.1038\/jid.1994.22","volume":"103","author":"W Bergman","year":"1994","unstructured":"Bergman, W., Gruis, N.A., Sandkuijl, L.A. & Frants, R.R. Genetics of seven Dutch familial atypical multiple mole-melanoma syndrome families: a review of linkage results including chromosomes 1 and 9.  J. Invest. Dermatol. 103, 122S\u2013125S (1994).","journal-title":"J. Invest. Dermatol."},{"key":"BFng0199_128_CR2","first-page":"489","volume":"54","author":"AM Goldstein","year":"1994","unstructured":"Goldstein, A.M. et al. Linkage of cutaneous malignant melanoma\/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity. Am. J. Hum. Genet. 54, 489\u2013496 (1994).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng0199_128_CR3","first-page":"188","volume":"38","author":"SJ Bale","year":"1986","unstructured":"Bale, S.J., Chakravarti, A. & Greene, M.H. Cutaneous malignant melanoma and familial dysplastic nevi: evidence for autosomal dominance and pleiotropy. Am. J. Hum. Genet. 38, 188\u2013196 ( 1986).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng0199_128_CR4","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1126\/science.1439824","volume":"258","author":"LA Cannon-Albright","year":"1992","unstructured":"Cannon-Albright, L.A. et al. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 258, 1148\u2013 1152 (1992).","journal-title":"Science"},{"key":"BFng0199_128_CR5","first-page":"6041","volume":"54","author":"LA Cannon-Albright","year":"1994","unstructured":"Cannon-Albright, L.A. et al. Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res. 54, 6041\u20136044 (1994).","journal-title":"Cancer Res."},{"key":"BFng0199_128_CR6","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1093\/jnci\/86.18.1385","volume":"86","author":"AM Goldstein","year":"1994","unstructured":"Goldstein, A.M., Fraser, M.C., Clark, W.H. Jr & Tucker, M.A. Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma\/dysplastic nevi. J. Natl Cancer. Inst.  86, 1385\u20131390 ( 1994).","journal-title":"J. Natl Cancer. Inst."},{"key":"BFng0199_128_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0733-8635(18)30066-4","volume":"13","author":"AM Goldstein","year":"1995","unstructured":"Goldstein, A.M. & Tucker, M.A. Genetic epidemiology of familial melanoma. Dermatol. Clin. 13, 605\u2013612 (1995).","journal-title":"Dermatol. Clin."},{"key":"BFng0199_128_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/120347549800200312","volume":"2","author":"D Hogg","year":"1998","unstructured":"Hogg, D. et al. Role of the cyclin-dependent kinase inhibitor CDKN2A in familial melanoma. J. Cutan. Med. Surg. 2, 172\u2013 179 (1998).","journal-title":"J. Cutan. Med. Surg."},{"key":"BFng0199_128_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/00001622-199603000-00011","volume":"8","author":"NK Hayward","year":"1996","unstructured":"Hayward, N.K. The current situation with regard to human melanoma and genetic inferences. Curr. Opin. Oncol. 8, 136\u2013 142 (1996).","journal-title":"Curr. Opin. Oncol."},{"key":"BFng0199_128_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0168-9525(00)89027-7","volume":"11","author":"A Kamb","year":"1995","unstructured":"Kamb, A. Cell-cycle regulators and cancer. Trends Genet. 11, 136\u2013140 (1995).","journal-title":"Trends Genet."},{"key":"BFng0199_128_CR11","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1101\/gad.9.10.1149","volume":"9","author":"CJ Sherr","year":"1995","unstructured":"Sherr, C.J. & Roberts, J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149\u2013 1163 (1995).","journal-title":"Genes Dev."},{"key":"BFng0199_128_CR12","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","volume":"274","author":"CJ Sherr","year":"1996","unstructured":"Sherr, C.J. Cancer cell cycles. Science 274, 1672\u2013 1677 (1996).","journal-title":"Science"},{"key":"BFng0199_128_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/ng0994-15","volume":"8","author":"CJ Hussussian","year":"1994","unstructured":"Hussussian, C.J. et al. Germline p16 mutations in familial melanoma.  Nature Genet. 8, 15\u201321 ( 1994).","journal-title":"Nature Genet."},{"key":"BFng0199_128_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/ng0994-22","volume":"8","author":"A Kamb","year":"1994","unstructured":"Kamb, A. et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet.  8, 23\u201326 (1994).","journal-title":"Nature Genet."},{"key":"BFng0199_128_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/00008390-199506000-00005","volume":"5","author":"NA Gruis","year":"1995","unstructured":"Gruis, N.A., Sandkuijl, L.A., van der Velden, P.A., Bergman, W. & Frants, R.R. CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families. Melanoma Res. 5, 169\u2013 177 (1995).","journal-title":"Melanoma Res."},{"key":"BFng0199_128_CR16","first-page":"2289","volume":"11","author":"EA Holland","year":"1995","unstructured":"Holland, E.A.  et al. Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds. Oncogene 11, 2289\u2013 2294 (1995).","journal-title":"Oncogene"},{"key":"BFng0199_128_CR17","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/hmg\/4.10.1845","volume":"4","author":"GJ Walker","year":"1995","unstructured":"Walker, G.J.  et al. Mutations of the CDKN2\/p16INK4 gene in Australian melanoma kindreds. Hum. Mol. Genet. 4, 1845\u2013 1852 (1995).","journal-title":"Hum. Mol. Genet."},{"key":"BFng0199_128_CR18","first-page":"405","volume":"11","author":"L Liu","year":"1995","unstructured":"Liu, L. et al. Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma. Oncogene 11, 405 \u2013412 (1995).","journal-title":"Oncogene"},{"key":"BFng0199_128_CR19","doi-asserted-by":"publisher","first-page":"8541","DOI":"10.1073\/pnas.93.16.8541","volume":"93","author":"MG FitzGerald","year":"1996","unstructured":"FitzGerald, M.G. et al. Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.  Proc. Natl Acad. Sci. USA 93, 8541\u2013 8545 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFng0199_128_CR20","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1056\/NEJM199803263381305","volume":"338","author":"J Monzon","year":"1998","unstructured":"Monzon, J.  et al. CDKN2A mutations in multiple primary melanomas.  N. Engl. J. Med. 338, 879\u2013887 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFng0199_128_CR21","doi-asserted-by":"publisher","first-page":"8798","DOI":"10.1073\/pnas.89.18.8798","volume":"89","author":"NC Bergenhem","year":"1992","unstructured":"Bergenhem, N.C., Venta, P.J., Hopkins, P.J., Kim, H.J. & Tashian, R.E. Mutation creates an open reading frame within the 5\u00b4 untranslated region of macaque erythrocyte carbonic anhydrase (CA) I mRNA that suppresses CA I expression and supports the scanning model for translation. Proc. Natl Acad. Sci. USA 89 , 8798\u20138802 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFng0199_128_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/509","volume":"19","author":"H Krude","year":"1998","unstructured":"Krude, H.  et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nature Genet. 19, 155\u2013157 ( 1998).","journal-title":"Nature Genet."},{"key":"BFng0199_128_CR23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/(SICI)1098-1004(1998)11:6<424::AID-HUMU2>3.0.CO;2-2","volume":"11","author":"PM Pollock","year":"1998","unstructured":"Pollock, P.M.  et al. Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families: evidence for common founders and independent mutations. Hum. Mutat. 11, 424\u2013431 (1998).","journal-title":"Hum. Mutat."},{"key":"BFng0199_128_CR24","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1093\/hmg\/3.12.2195","volume":"3","author":"C MacGeoch","year":"1994","unstructured":"MacGeoch, C.  et al. Genetic heterogeneity in familial malignant melanoma.  Hum. Mol. Genet. 3, 2195\u20132200 (1994).","journal-title":"Hum. Mol. Genet."},{"key":"BFng0199_128_CR25","first-page":"2497","volume":"56","author":"A Borg","year":"1996","unstructured":"Borg, A. et al. Novel germline p16 mutation in familial malignant melanoma in southern Sweden. Cancer Res. 56, 2497\u2013 2500 (1996).","journal-title":"Cancer Res."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng0199_128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng0199_128","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng0199_128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:19:10Z","timestamp":1684441150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng0199_128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["BFng0199_128"],"URL":"https:\/\/doi.org\/10.1038\/5082","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}